Wednesday, November 13, 2024
HomeNews

News

NRx Pharmaceuticals Announces Data Safety Monitoring Board (DSMB) Update on U.S. National Institutes of Health (NIH) Study of ZYESAMI (aviptadil) in Critical COVID-19

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced results of a review conducted by the Data Safety and Monitoring Board (DSMB) on May 25,...

Signant Introduces Oncology Complete, Featuring Comprehensive Clinical Technology for Optimizing Modern Oncology Trials

Signant Health, the leader in evidence generation for modern clinical trials, introduced a new solution bundle to address specific challenges and evolving needs in...

SeekIn Receives CE Mark Approval for SeekInClarity Cancer Treatment Response Monitoring Kit

SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, announced CE (ConformitéEuropéenne) Mark approval for SeekInClarityTM Cancer Treatment Response Monitoring Kit...

Skylinedx Announces Medicare Coverage for Its Predictive Melanoma Assay Merlin Test

SkylineDx, a leading molecular diagnostics company, announces Medicare coverage for Merlin Test. The local coverage determination was issued under the foundational policy "Melanoma Risk...

Vivera Receives 3rd U.S. Patent Allowance for ZICOH Drug Delivery Device

Vivera is pleased to announce the allowance of its third U.S. patent for ZICOH, the Company's high-tech, electronic dose-controlled portfolio of drug delivery devices....
0FansLike
0FollowersFollow
spot_img

Hot Topics